Role of biological response modifiers in the treatment of tumors Peter Reizenstein Editorial Pages: 1 - 1
Thymomodulin: biological properties and clinical applications N. M. KouttabM. PradaP. Cazzola OriginalPaper Pages: 5 - 9
Therapy of secondary T-cell immunodeficiencies with biological substances and drugs John W. HaddenElba M. Hadden OriginalPaper Pages: 11 - 17
Therapeutic application of calf thymus extract (TFX) Aleksander B. Skotnicki OriginalPaper Pages: 31 - 43
Modulation of NK activity by thymic hormones:in vitro effects of thymostimulin Anna Marina LiberatiSaverio CinieriLucia Palmisano OriginalPaper Pages: 45 - 52
Preliminary results on clinical and immunological effects of thymus hormone preparations in AIDS Philippe HermansNathan Clumeck OriginalPaper Pages: 55 - 58
Effect of the immunomodulator LF 1695 on T-lymphocytes and macrophages. Activity in HIV infection Jean-Louis Touraine OriginalPaper Pages: 59 - 61
Clinical and immunological assessment in HIV+ subjects receiving inosine-pranobex. A randomised, multicentric study C. De SimoneF. AlbertiniV. Vullo OriginalPaper Pages: 63 - 67
4′-O-Tetrahydropyranyl adriamycin (THP-ADM)-induced modifications of murine peritoneal macrophages A. Bravo-CuellarG. MathéS. Orbach-Arbouys OriginalPaper Pages: 71 - 75
Cyclophosphamide and melphalan as immunopotentiating agents in cancer therapy Sheldon DrayMargalit B. Mokyr OriginalPaper Pages: 77 - 85
The clinical use of monoclonal antibodies, MAb 17-1A, in the treatment of patients with metastatic colorectal carcinoma H. MellstedtJ. E. FrödinR. Erwald OriginalPaper Pages: 99 - 107
Cimetidine as an immune response modifier Robert HastPer BernellMona Hansson OriginalPaper Pages: 111 - 113